Year of the Rabbit greetings from MONOPOLY Dreams(TM) with fea... - 23 February 2023 17:20

HONG KONG, Feb. 23, 2023 /PRNewswire-AsiaNet/ -- Starting from Year of the Rabbit, MONOPOLY Dreams(TM) strives to provide a creative service to tourists with "MONOPOLY Postcards". Tourists and their relatives and friends can feel blessings from MONOPOLY Dreams(TM). From now till 31 March 2023...

  Xinhua Silk Road: China's Pu'er sees booming coffee bean expor... - 23 February 2023 16:10

BEIJING, Feb. 23, 2023 /PRNewswire-AsiaNet/ -- The export value of green coffee beans produced in Pu'er City, southwest China's Yunnan Province, reached 462 million yuan in 2022, surging 296.4 percent year on year, according to a recent report by Pu'er Daily. Export destinations included Eu...

  CapitaLand Investment establishes China data centre developmen... - 22 February 2023 16:36

SINGAPORE, Feb. 22, 2023 /PRNewswire-AsiaNet/ -- - CapitaLand China Data Centre Partners will develop two hyperscale data centres in Greater Beijing, bringing CapitaLand's data centre portfolio to 26 across Asia and Europe CapitaLand Investment Limited (CLI) has established a China data cent...

  3 Highlights of Huawei's Green Intelligent OptiX Network will ... - 21 February 2023 23:51

BARCELONA, Spain, Feb. 21, 2023 /PRNewswire-AsiaNet/ -- Driven by the needs of the smart society, the bandwidth requirements of the campus, industrial interconnection, enterprise and home scenarios are increasing, and people's demand for network connectivity is developing at a speed far faster than we ...

  Japanese Only - 21 February 2023 18:00

SHANGHAI, Feb. 21, 2023 /PRNewswire-Asianet/ -- JP only

  Japanese only - 21 February 2023 14:01

HAIKOU, China, Feb. 21, 2023 /PRNewswire-AsiaNet/ -- Please find attached client provided Japanese version

  Significant Progress Made on the Trivalent Recombinant Protein... - 20 February 2023 16:12

CHENGDU, China, Feb. 20, 2023 /PRNewswire-AsiaNet/ -- Recently, with the support of the National Key R&D Program of China, following the clinical trial approval for Recombinant Variant COVID-19 Vaccine (Sf9 cell) approved by NMPA, WestVac Biopharma (Guangzhou) Co., Ltd. (hereinafter referred to as "W...

  The Physical 133rd Canton Fair Prepares Worry-free Services an... - 17 February 2023 20:52

GUANGZHOU, China, Feb. 17, 2023 /PRNewswire-AsiaNet/ -- The 133rd China Import and Export Fair ("Canton Fair" or "the Fair"), scheduled to open in April 2023, will fully integrate online and physical exhibitions as China's entry policy is adjusted and opened up. Canton Fair invitation application and p...

  CGTN: China achieves 'major, decisive' victory in COVID-19 res... - 17 February 2023 19:03

BEIJING, Feb. 17, 2023 /PRNewswire-AsiaNet/ -- Over the past three years, China has always been putting people's lives and health first and adapting its COVID-19 response in light of the evolving situation, in efforts widely believed to have bought precious time for a smooth transition. The...

  Japanese only - 17 February 2023 18:08

TOKYO, Feb. 17, 2023 /PRNewswire-AsiaNet/ -- Please find attached the JP provided by client